Interaction of the papillomavirus transcription/replication factor, E2, and the viral capsid protein, L2

Virology

Volumn 276, Issue 2, 2000, Pages 304-314

  Heino, Pirkko ^a   Zhou, Jian ^b   Lambert, Paul F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GENE PRODUCT; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; DNA REPLICATION; GENE REPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; VIRION; VIRUS CAPSID; VIRUS INFECTIVITY;

EID: 0034715583     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0342     Document Type: Article

References (43)

1. Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML
2. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells
3. Evidence that the transcriptional trans-activating function of the bovine papillomavirus type 1 E2 gene is not required for viral DNA amplification in division-arrested cells
4. Mechanism of action of the papillomavirus E2 repressor. Repression in the absence of DNA binding
5. Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins
6. Bovine papillomavirus E1 protein can, by itself, efficiently drive multiple rounds of DNA synthesis in vitro
7. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies
8. Bovine papillomavirus type 1 encodes two forms of a transcriptional repressor. Structural and functional analysis of new viral cDNAs
9. The open reading frame L2 of cottontail rabbit papilloma-virus contains antibody-inducing neutralizing epitopes
10. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains
11. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle
12. El protein of human papillomavirus type 1a is sufficient for initiation of viral DNA replication
13. A new technique for the assay of infectivity of human adenovirus 5 DNA
14. Human papillomavirus type 16 capsid proteins produced from recombinant Semliki Forest virus assemble into virus-like particles
15. Molecular and serological studies of human papillomavirus among patients with anal epidermoid carcinoma
16. The 23-kilodalton E1 phosphoprotein of bovine papillomavirus type 1 is nonessential for stable plasmid replication in murine C127 cells
17. Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which is mediated by the viral E2 protein and its binding sites
18. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
19. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles
20. Functional analysis of the papilloma virus E2 trans-activator in Saccharomyces cerevisiae
21. Phenotypic analysis of bovine papillomavirus type 1 E2 repressor mutants
22. A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator
23. Segregation of viral plasmids depends on tethering to chromosomes and is regulated by phosphorylation
24. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1
25. The carboxy-terminal domain shared by the bovine papillomavirus E2 transactivator and repressor proteins contains a specific DNA binding activity
26. EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication
27. Replication of bovine papillomavirus type 1 origin-containing DNA in crude extracts and with purified proteins
28. Bovine papillomavirus type 1 E2 transcriptional regulators directly bind two cellular transcription factors, TFIID and TFIIB
29. Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions
30. Transformation and replication in mouse cells of a bovine papillomavirus-pML2 plasmid vector that can be rescued in bacteria
31. Bovine papillomavirus type 1 genomes and the E2 transactivator protein are closely associated with mitotic chromatin
32. Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product
33. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies
34. Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution
35. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames
36. Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1
37. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells
38. Bovine papillomavirus contains multiple transforming genes
39. Functional interaction of the bovine papillomavirus E2 transactivation domain with TFIIB
40. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability
41. Synthesis and assembly of infectious bovine papillomavirus particles in vitro
42. Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence
43. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles